Report Detail
Global Biodegradable Medical Polymer Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4723165 |
- 21 July, 2026 |
- Global |
- 111 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Biodegradable Medical Polymer market size was valued at US$ 1025 million in 2025 and is forecast to a readjusted size of US$ 1393 million by 2032 with a CAGR of 4.4% during review period.
Biodegradable Medical Polymer refers to a class of biocompatible polymer materials engineered to gradually decompose through biological, hydrolytic, or enzymatic processes within physiological environments, enabling temporary medical functionality and eventual safe elimination or absorption by the body, widely used in implants, sutures, drug delivery systems, wound care products, tissue engineering scaffolds, and regenerative medicine applications to reduce long-term foreign body presence and minimize secondary surgical procedures.
The Biodegradable Medical Polymer industry chain includes upstream suppliers of bio-based monomers, petrochemical intermediates, catalysts, specialty additives, medical-grade chemicals, and precision polymerization equipment, while midstream manufacturers perform polymer synthesis, purification, compounding, extrusion, molding, sterilization, surface modification, and regulatory validation to produce biodegradable medical-grade materials and components, and downstream sectors include medical device manufacturers, pharmaceutical companies, hospitals, biotechnology firms, tissue engineering enterprises, orthopedic implant producers, and regenerative medicine providers that utilize these polymers in implants, sutures, drug delivery systems, and biodegradable medical devices, with increasing market demand supported by aging populations, minimally invasive treatment adoption, and continuous biomaterials innovation across global healthcare industries.
Current projects under construction and planning within the Biodegradable Medical Polymer market include advanced biomaterials manufacturing facilities, biodegradable orthopedic implant production plants, regenerative medicine material development centers, controlled drug delivery polymer expansion projects, biodegradable cardiovascular device commercialization programs, tissue engineering scaffold pilot facilities, and 3D-printed medical polymer research initiatives across North America, Europe, China, Japan, South Korea, and Southeast Asia, where increasing demand for minimally invasive and sustainable medical technologies is accelerating investment activity, while manufacturers and biotechnology companies are simultaneously expanding GMP cleanroom infrastructure, polymer synthesis capabilities, clinical research collaborations, biomaterials testing laboratories, and strategic partnerships with hospitals, pharmaceutical companies, universities, and medical device manufacturers to improve innovation capacity and regulatory competitiveness.
2025 Global Market Average Gross Profit Margin: 40%.
The Biodegradable Medical Polymer market has experienced strong growth due to increasing demand for advanced biomaterials, minimally invasive medical procedures, and environmentally sustainable healthcare solutions. The market is shifting from conventional permanent implant materials toward biodegradable alternatives capable of safely degrading after completing therapeutic functions, reducing the need for secondary surgeries and improving patient recovery outcomes. Rising healthcare expenditures, aging populations, increasing orthopedic and cardiovascular disease prevalence, and technological advances in regenerative medicine continue to support long-term market expansion. North America remains a leading market due to its advanced medical device industry, strong biotechnology ecosystem, and extensive clinical research infrastructure. Europe maintains significant market share because of strict medical quality standards, strong regulatory frameworks, and increasing focus on sustainable healthcare technologies. Asia-Pacific, particularly China, Japan, and South Korea, is emerging as a major growth region supported by expanding healthcare systems, increasing domestic medical device production, and government support for biotechnology innovation.
Market development opportunities are closely associated with the rapid expansion of regenerative medicine, tissue engineering, biodegradable implants, and controlled drug delivery technologies. Increasing demand for biodegradable orthopedic fixation devices, cardiovascular stents, wound closure materials, and tissue scaffolds continues to create substantial growth potential. Technological advances in nanotechnology, 3D bioprinting, bioactive composites, and smart drug delivery systems are further expanding the application scope of biodegradable medical polymers. Pharmaceutical companies and biotechnology firms are increasingly investing in polymer-based therapeutics capable of improving drug efficacy and reducing systemic side effects. However, the market also faces several risks, including high research and development costs, lengthy regulatory approval cycles, strict biocompatibility requirements, and technical challenges related to degradation consistency and long-term mechanical stability. Material sterilization sensitivity, variability in physiological degradation behavior, and potential inflammatory responses may affect clinical adoption and commercialization timelines. Intellectual property barriers and complex regulatory compliance requirements may also limit participation from smaller manufacturers.
Competitive characteristics within the Biodegradable Medical Polymer market are defined by technological innovation, regulatory expertise, biomaterial performance, and strategic collaboration capabilities. Large multinational biomaterials companies and medical device manufacturers maintain advantages in research investment, global regulatory approvals, clinical validation, and large-scale production infrastructure. Emerging biotechnology firms and specialized biomaterial developers compete through proprietary polymer formulations, customized degradation technologies, and niche medical applications. Strategic partnerships between polymer producers, pharmaceutical companies, medical device developers, research institutes, and healthcare providers are becoming increasingly important for accelerating product development and commercialization. The market is also witnessing rising investment in AI-assisted biomaterial design, patient-specific implants, and advanced tissue regeneration platforms.
This report is a detailed and comprehensive analysis for global Biodegradable Medical Polymer market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biodegradable Medical Polymer market size and forecasts, in consumption value ($ Million), 2021-2032
Global Biodegradable Medical Polymer market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biodegradable Medical Polymer market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biodegradable Medical Polymer market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biodegradable Medical Polymer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biodegradable Medical Polymer market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Evonik, Corbion, DSM-Firmenich, Poly-Med, Ashland, Forécreu, Zeus Company LLC, REVA, DuPont, BMG Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biodegradable Medical Polymer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Polycaprolactone (PCL)
Polylactic-co-Glycolic Acid (PLGA)
Others
Market segment by Manufacturing Technology Type
Injection Molded
Extruded
Others
Market segment by Source Material Type
Synthetic Bioresorbable
Natural Bioresorbable
Bio-Based Bioresorbable
Hybrid Composite Bioresorbable
Others
Market segment by Application
Orthopedic Implants
Cardiovascular Stents
Drug Delivery Systems
Surgical Sutures
Others
Market segment by players, this report covers
Evonik
Corbion
DSM-Firmenich
Poly-Med
Ashland
Forécreu
Zeus Company LLC
REVA
DuPont
BMG Inc
Geon Performance Solutions LLC
Bezwada Biomedical LLC
Mitsui Chemicals
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biodegradable Medical Polymer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biodegradable Medical Polymer, with revenue, gross margin, and global market share of Biodegradable Medical Polymer from 2021 to 2026.
Chapter 3, the Biodegradable Medical Polymer competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biodegradable Medical Polymer market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biodegradable Medical Polymer.
Chapter 13, to describe Biodegradable Medical Polymer research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Biodegradable Medical Polymer by Type
- 1.3.1 Overview: Global Biodegradable Medical Polymer Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Biodegradable Medical Polymer Consumption Value Market Share by Type in 2025
- 1.3.3 Polylactic Acid (PLA)
- 1.3.4 Polyglycolic Acid (PGA)
- 1.3.5 Polycaprolactone (PCL)
- 1.3.6 Polylactic-co-Glycolic Acid (PLGA)
- 1.3.7 Others
- 1.4 Classification of Biodegradable Medical Polymer by Manufacturing Technology Type
- 1.4.1 Overview: Global Biodegradable Medical Polymer Market Size by Manufacturing Technology Type: 2021 Versus 2025 Versus 2032
- 1.4.2 Global Biodegradable Medical Polymer Consumption Value Market Share by Manufacturing Technology Type in 2025
- 1.4.3 Injection Molded
- 1.4.4 Extruded
- 1.4.5 Others
- 1.5 Classification of Biodegradable Medical Polymer by Source Material Type
- 1.5.1 Overview: Global Biodegradable Medical Polymer Market Size by Source Material Type: 2021 Versus 2025 Versus 2032
- 1.5.2 Global Biodegradable Medical Polymer Consumption Value Market Share by Source Material Type in 2025
- 1.5.3 Synthetic Bioresorbable
- 1.5.4 Natural Bioresorbable
- 1.5.5 Bio-Based Bioresorbable
- 1.5.6 Hybrid Composite Bioresorbable
- 1.5.7 Others
- 1.6 Global Biodegradable Medical Polymer Market by Application
- 1.6.1 Overview: Global Biodegradable Medical Polymer Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Orthopedic Implants
- 1.6.3 Cardiovascular Stents
- 1.6.4 Drug Delivery Systems
- 1.6.5 Surgical Sutures
- 1.6.6 Others
- 1.7 Global Biodegradable Medical Polymer Market Size & Forecast
- 1.8 Global Biodegradable Medical Polymer Market Size and Forecast by Region
- 1.8.1 Global Biodegradable Medical Polymer Market Size by Region: 2021 VS 2025 VS 2032
- 1.8.2 Global Biodegradable Medical Polymer Market Size by Region, (2021-2032)
- 1.8.3 North America Biodegradable Medical Polymer Market Size and Prospect (2021-2032)
- 1.8.4 Europe Biodegradable Medical Polymer Market Size and Prospect (2021-2032)
- 1.8.5 Asia-Pacific Biodegradable Medical Polymer Market Size and Prospect (2021-2032)
- 1.8.6 South America Biodegradable Medical Polymer Market Size and Prospect (2021-2032)
- 1.8.7 Middle East & Africa Biodegradable Medical Polymer Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Evonik
- 2.1.1 Evonik Details
- 2.1.2 Evonik Major Business
- 2.1.3 Evonik Biodegradable Medical Polymer Product and Solutions
- 2.1.4 Evonik Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Evonik Recent Developments and Future Plans
- 2.2 Corbion
- 2.2.1 Corbion Details
- 2.2.2 Corbion Major Business
- 2.2.3 Corbion Biodegradable Medical Polymer Product and Solutions
- 2.2.4 Corbion Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Corbion Recent Developments and Future Plans
- 2.3 DSM-Firmenich
- 2.3.1 DSM-Firmenich Details
- 2.3.2 DSM-Firmenich Major Business
- 2.3.3 DSM-Firmenich Biodegradable Medical Polymer Product and Solutions
- 2.3.4 DSM-Firmenich Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 DSM-Firmenich Recent Developments and Future Plans
- 2.4 Poly-Med
- 2.4.1 Poly-Med Details
- 2.4.2 Poly-Med Major Business
- 2.4.3 Poly-Med Biodegradable Medical Polymer Product and Solutions
- 2.4.4 Poly-Med Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Poly-Med Recent Developments and Future Plans
- 2.5 Ashland
- 2.5.1 Ashland Details
- 2.5.2 Ashland Major Business
- 2.5.3 Ashland Biodegradable Medical Polymer Product and Solutions
- 2.5.4 Ashland Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Ashland Recent Developments and Future Plans
- 2.6 Forécreu
- 2.6.1 Forécreu Details
- 2.6.2 Forécreu Major Business
- 2.6.3 Forécreu Biodegradable Medical Polymer Product and Solutions
- 2.6.4 Forécreu Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Forécreu Recent Developments and Future Plans
- 2.7 Zeus Company LLC
- 2.7.1 Zeus Company LLC Details
- 2.7.2 Zeus Company LLC Major Business
- 2.7.3 Zeus Company LLC Biodegradable Medical Polymer Product and Solutions
- 2.7.4 Zeus Company LLC Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Zeus Company LLC Recent Developments and Future Plans
- 2.8 REVA
- 2.8.1 REVA Details
- 2.8.2 REVA Major Business
- 2.8.3 REVA Biodegradable Medical Polymer Product and Solutions
- 2.8.4 REVA Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 REVA Recent Developments and Future Plans
- 2.9 DuPont
- 2.9.1 DuPont Details
- 2.9.2 DuPont Major Business
- 2.9.3 DuPont Biodegradable Medical Polymer Product and Solutions
- 2.9.4 DuPont Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 DuPont Recent Developments and Future Plans
- 2.10 BMG Inc
- 2.10.1 BMG Inc Details
- 2.10.2 BMG Inc Major Business
- 2.10.3 BMG Inc Biodegradable Medical Polymer Product and Solutions
- 2.10.4 BMG Inc Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 BMG Inc Recent Developments and Future Plans
- 2.11 Geon Performance Solutions LLC
- 2.11.1 Geon Performance Solutions LLC Details
- 2.11.2 Geon Performance Solutions LLC Major Business
- 2.11.3 Geon Performance Solutions LLC Biodegradable Medical Polymer Product and Solutions
- 2.11.4 Geon Performance Solutions LLC Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Geon Performance Solutions LLC Recent Developments and Future Plans
- 2.12 Bezwada Biomedical LLC
- 2.12.1 Bezwada Biomedical LLC Details
- 2.12.2 Bezwada Biomedical LLC Major Business
- 2.12.3 Bezwada Biomedical LLC Biodegradable Medical Polymer Product and Solutions
- 2.12.4 Bezwada Biomedical LLC Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Bezwada Biomedical LLC Recent Developments and Future Plans
- 2.13 Mitsui Chemicals
- 2.13.1 Mitsui Chemicals Details
- 2.13.2 Mitsui Chemicals Major Business
- 2.13.3 Mitsui Chemicals Biodegradable Medical Polymer Product and Solutions
- 2.13.4 Mitsui Chemicals Biodegradable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Mitsui Chemicals Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Biodegradable Medical Polymer Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Biodegradable Medical Polymer by Company Revenue
- 3.2.2 Top 3 Biodegradable Medical Polymer Players Market Share in 2025
- 3.2.3 Top 6 Biodegradable Medical Polymer Players Market Share in 2025
- 3.3 Biodegradable Medical Polymer Market: Overall Company Footprint Analysis
- 3.3.1 Biodegradable Medical Polymer Market: Region Footprint
- 3.3.2 Biodegradable Medical Polymer Market: Company Product Type Footprint
- 3.3.3 Biodegradable Medical Polymer Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Biodegradable Medical Polymer Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Biodegradable Medical Polymer Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Biodegradable Medical Polymer Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Biodegradable Medical Polymer Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Biodegradable Medical Polymer Consumption Value by Type (2021-2032)
- 6.2 North America Biodegradable Medical Polymer Market Size by Application (2021-2032)
- 6.3 North America Biodegradable Medical Polymer Market Size by Country
- 6.3.1 North America Biodegradable Medical Polymer Consumption Value by Country (2021-2032)
- 6.3.2 United States Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 6.3.3 Canada Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Biodegradable Medical Polymer Consumption Value by Type (2021-2032)
- 7.2 Europe Biodegradable Medical Polymer Consumption Value by Application (2021-2032)
- 7.3 Europe Biodegradable Medical Polymer Market Size by Country
- 7.3.1 Europe Biodegradable Medical Polymer Consumption Value by Country (2021-2032)
- 7.3.2 Germany Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 7.3.3 France Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 7.3.5 Russia Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 7.3.6 Italy Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Biodegradable Medical Polymer Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Biodegradable Medical Polymer Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Biodegradable Medical Polymer Market Size by Region
- 8.3.1 Asia-Pacific Biodegradable Medical Polymer Consumption Value by Region (2021-2032)
- 8.3.2 China Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 8.3.3 Japan Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 8.3.5 India Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 8.3.7 Australia Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Biodegradable Medical Polymer Consumption Value by Type (2021-2032)
- 9.2 South America Biodegradable Medical Polymer Consumption Value by Application (2021-2032)
- 9.3 South America Biodegradable Medical Polymer Market Size by Country
- 9.3.1 South America Biodegradable Medical Polymer Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Biodegradable Medical Polymer Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Biodegradable Medical Polymer Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Biodegradable Medical Polymer Market Size by Country
- 10.3.1 Middle East & Africa Biodegradable Medical Polymer Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
- 10.3.4 UAE Biodegradable Medical Polymer Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Biodegradable Medical Polymer Market Drivers
- 11.2 Biodegradable Medical Polymer Market Restraints
- 11.3 Biodegradable Medical Polymer Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Biodegradable Medical Polymer Industry Chain
- 12.2 Biodegradable Medical Polymer Upstream Analysis
- 12.3 Biodegradable Medical Polymer Midstream Analysis
- 12.4 Biodegradable Medical Polymer Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Biodegradable Medical Polymer. Industry analysis & Market Report on Biodegradable Medical Polymer is a syndicated market report, published as Global Biodegradable Medical Polymer Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Biodegradable Medical Polymer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
